State-of-the-art review: allogeneic stem cell transplantation for myelofibrosis in 2019

Advances in understanding the pathogenesis and molecular landscape of myelofibrosis have occurred over the last decade. Treating physicians now have access to an ever-evolving armamentarium of novel agents to treat patients, although allogeneic hematopoietic stem cell transplantation remains the onl...

Descripción completa

Detalles Bibliográficos
Autores principales: McLornan, Donal P., Yakoub-Agha, Ibrahim, Robin, Marie, Chalandon, Yves, Harrison, Claire N., Kroger, Nicolaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442950/
https://www.ncbi.nlm.nih.gov/pubmed/30872371
http://dx.doi.org/10.3324/haematol.2018.206151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442950/
https://www.ncbi.nlm.nih.gov/pubmed/30872371
http://dx.doi.org/10.3324/haematol.2018.206151

Ejemplares similares